Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Jul 21, 2014
SEATTLE, July 21, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2014 second quarter financial results after the close of trading on Tuesday, August 5, 2014. Company management will host...
Jun 11, 2014
SEATTLE, June 11, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the JMP Securities Healthcare Conference 2014 in New York. NanoString management is scheduled to present on Wednesday, June 25, 2014 at 9:00 am ET. Interested parties can access the live ...
Jun 3, 2014
NanoString Eligible to Receive up to $45 million for Upfront, Developmental and Regulatory Milestones, and Commercial Payments from Celgene SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecul...
May 19, 2014
SEATTLE, May 19, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Jefferies 2014 Global Healthcare Conference in New York. NanoString management is scheduled to present on Wednesday, June 4, 2014 at 4:00 pm ET. Interested parties can access the live ...
May 7, 2014
- Strong Q1 2014 Revenue Growth of 54% Year over Year - - Q1 2014 Instrument Revenue of $3.4 Million, Up 110% Year over Year - SEATTLE, May 7, 2014 (GLOBE NEWSWIRE) --NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial result...
May 6, 2014
The Prosigna Assay on the nCounter Dx Analysis System Provides Compelling Clinical Data, Clear Patient Report, and Localized Processing in Qualified Canadian Labs SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translation...
May 1, 2014
SEATTLE, May 1, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Bank of America Merrill Lynch Healthcare Conference in Las Vegas. NanoString management is scheduled to present on Wednesday, May 14, 2014 at 4:00 pm ET. Interested parties can access t...
Apr 30, 2014
SEATTLE, April 30, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of veteran diagnostics executive Tina S. Nova, Ph.D. to its Board of Directors. Dr. Nova will also join the Board's Compensation Commi...
Apr 16, 2014
SEATTLE, April 16, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2014 first quarter financial results after the close of trading on Wednesday, May 7, 2014. Company management will host ...
Apr 7, 2014
nCounter PanCancer Pathways Panel Streamlines the Study of All Major Cancer Pathways and Associated Driver Genes SEATTLE & SAN DIEGO--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagn...
Apr 3, 2014
SEATTLE, April 3, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a term loan agreement with Capital Royalty L.P. and certain of its affiliates. The agreement provides NanoString with up to $4...
Mar 13, 2014
Successful Validation on the nCounter Dx Analysis System Supports ‘Decentralized' Use of the Prosigna Assay in Clinical Laboratories SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnos...
Feb 26, 2014
- Strong Q4 2013 Revenue Growth of 56% Year over Year - - Record Q4 2013 Instrument Revenue of $5.3 Million, Up 109% Year over Year - - Full Year Total Revenue of $31.4 Million, Up 37% Year over Year - SEATTLE, Feb. 26, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for tran...
Feb 19, 2014
SEATTLE, Feb. 19, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Cowen 34th Annual Health Care Conference in Boston. NanoString management is scheduled to present on Wednesday, March 5, 2014 at 11:20 am ET. Interested parties can access the live au...
Feb 12, 2014
Authors Conclude that the PAM50-based Prosigna Assay can Predict Risk of Late Distant Recurrence Between Years Five and 15 after Diagnosis SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnos...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase